Riskpilot← Back to searchSign inGet full accessLEGE HÅVARD ORLIEN AS
ASActiveOrg 913406338Vesterveien 44, 4839 ArendalGeneral medical practice activities · NACE 8621Est. 20141 employees
Revenue 2024
NOK 2M
-18% vs 2023
EBITDA margin
15.2%
-64% vs 2023
Equity ratio
90.6%
Financial strength
Net profit 2024
NOK 302K
-60% vs 2023
| Revenue | NOK 2M | -18% |
| EBITDA | NOK 304K | -64% |
| Net profit | NOK 302K | -60% |
| Total assets | NOK 4,4M | +7% |
| Equity | NOK 4M | +8% |
| Employees | 1 | — |
Legal name
LEGE HÅVARD ORLIEN AS
Org number
913406338
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
24. mars 2014
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder eller styrets leder hver for seg.
Company purpose
Legevirksomhet og annet som naturlig hører sammen med dette, samt kapitalplasseringer og deltagelse i andre virksomheter.
Address
Vesterveien 44, 4839 Arendal
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 198 | 2 396 | 2 418 | 2 446 | 1 994 |
| Staff expenses | −890 | −916 | −1 039 | −1 057 | −1 092 |
| EBITDA | 415 | 268 | 335 | 850 | 304 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −111 |
| EBIT | 415 | 268 | 335 | 850 | 193 |
| Net financials | 105 | 176 | 106 | 100 | 152 |
| Profit before tax | 519 | 444 | 441 | 950 | 345 |
| Tax | 160 | 60 | 75 | 187 | 42 |
| Net profit | 359 | 383 | 366 | 763 | 302 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 303 | 2 740 | 3 115 | 4 090 | 4 373 |
| Equity | 2 052 | 2 529 | 2 895 | 3 659 | 3 961 |
| Long-term debt | 12 | 5 | 5 | 5 | −11 |
| Short-term debt | 239 | 206 | 214 | 426 | 424 |
| Total debt | 251 | 211 | 219 | 431 | 413 |
EBITDA margin
15.2%
This company
15.8%
Market median
+4% vs market
20202024
Equity ratio
90.6%
This company
38.2%
Market median
+137% vs market
20202024
Return on equity
7.6%
This company
18.4%
Market median
-59% vs market
20202024
Net profit margin
15.2%
This company
8.1%
Market median
+88% vs market
20202024
Asset turnover
0.46×
This company
1.12×
Market median
-59% vs market
20202024
Debt / equity
0.10×
This company
0.62×
Market median
+84% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
LH Deputy Member | Deputy Member | 2014 |
HO Chief Executive Officer | Chief Executive Officer | 2014 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
LEGE HÅVARD ORLIEN AS 
MAXIS LEGESENTER ASBoard members of LEGE HÅVARD ORLIEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lene Hande Orlien | Deputy Member | 0 companies |
| Håvard Orlien | Chief Executive Officer | 0 companies |